Microbot Medical (MBOT) Stock Rating Reiterated by H.C. Wainwright

AI Summary

H.C. Wainwright has reiterated its rating on Microbot Medical (MBOT). However, no specific metrics, trading volumes, or changes in financial performance were provided in the announcement. This reaffirmation of the stock rating suggests continuity in market perception. Without concrete data, the impact on market movement remains unclear.